As we move forwards from the first wave of the COVID-19 epidemic, the approach to SARS-CoV-2 testing is also moving rapidly, both for viral detection and for testing the immune and protective immune responses to it. The initial wave has impacted, but further cases are likely unless and until an effective vaccine with long-term protective efficacy becomes available and widely used.
This document sets out a vision for a future strategy with which clinical, scientific and policy stakeholders, including patient advocacy groups, can align. It forms the basis for a roadmap to delivery. It applies equally to all settings in which care is delivered, across all our population, and all age groups.
This strategy is based on a set of seven principles, which underpin four key workstreams:
- testing matched to purpose and pathways
- innovation to adoption
- Infrastructure and workforce for a stable future
- SARS-CoV-2 is not the only virus.